FAT1
Basic information
Region (hg38): 4:186587794-186726722
Previous symbols: [ "FAT" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (9 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FAT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 293 | 39 | 334 | |||
missense | 507 | 76 | 34 | 617 | ||
nonsense | 14 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 4 | 12 | 1 | 17 | ||
non coding | 59 | 80 | 139 | |||
Total | 9 | 7 | 514 | 428 | 153 |
Highest pathogenic variant AF is 0.00000657
Variants in FAT1
This is a list of pathogenic ClinVar variants found in the FAT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-186588338-C-T | Benign (Apr 03, 2020) | |||
4-186588450-G-A | Likely benign (Mar 31, 2020) | |||
4-186588460-G-A | Benign (Nov 12, 2018) | |||
4-186588576-T-TG | Benign (Mar 15, 2020) | |||
4-186588585-T-C | FAT1-related disorder | Likely benign (Mar 09, 2022) | ||
4-186588601-C-G | Likely benign (Dec 17, 2023) | |||
4-186588632-G-A | not specified | Benign/Likely benign (Jan 11, 2024) | ||
4-186588637-C-T | FAT1-related disorder | Likely benign (Aug 17, 2023) | ||
4-186588654-C-G | Inborn genetic diseases | Uncertain significance (May 22, 2024) | ||
4-186588662-C-T | FAT1-related disorder | Uncertain significance (Mar 31, 2023) | ||
4-186588684-C-T | Inborn genetic diseases | Uncertain significance (Sep 07, 2022) | ||
4-186588687-C-T | Inborn genetic diseases | Uncertain significance (Jan 30, 2024) | ||
4-186588700-G-A | Likely benign (Oct 13, 2022) | |||
4-186588702-A-G | Inborn genetic diseases | Uncertain significance (Jan 24, 2024) | ||
4-186588707-G-C | Benign/Likely benign (Dec 18, 2023) | |||
4-186588714-C-T | Inborn genetic diseases | Uncertain significance (Jan 26, 2023) | ||
4-186588729-C-T | Inborn genetic diseases | Uncertain significance (Mar 07, 2023) | ||
4-186588732-T-C | FAT1-related disorder | Uncertain significance (Nov 17, 2022) | ||
4-186588739-G-A | FAT1-related disorder | Likely benign (Jan 15, 2024) | ||
4-186588752-G-C | Inborn genetic diseases | Uncertain significance (Dec 18, 2023) | ||
4-186588762-C-T | FAT1-related disorder | Uncertain significance (May 09, 2024) | ||
4-186588765-C-T | Inborn genetic diseases | Uncertain significance (Dec 07, 2021) | ||
4-186588769-G-A | Benign (Jan 12, 2024) | |||
4-186588773-G-A | Inborn genetic diseases | Likely benign (Aug 28, 2023) | ||
4-186588777-C-T | FAT1-related disorder | Benign/Likely benign (Jan 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FAT1 | protein_coding | protein_coding | ENST00000441802 | 26 | 138940 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.20e-12 | 1.00 | 124595 | 0 | 111 | 124706 | 0.000445 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.431 | 2611 | 2.55e+3 | 1.02 | 0.000151 | 30186 |
Missense in Polyphen | 868 | 965.34 | 0.89916 | 11603 | ||
Synonymous | -2.04 | 1129 | 1.05e+3 | 1.08 | 0.0000745 | 9126 |
Loss of Function | 7.35 | 49 | 144 | 0.340 | 0.00000787 | 1900 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000902 | 0.000898 |
Ashkenazi Jewish | 0.00119 | 0.00119 |
East Asian | 0.000561 | 0.000556 |
Finnish | 0.000279 | 0.000278 |
European (Non-Finnish) | 0.000444 | 0.000442 |
Middle Eastern | 0.000561 | 0.000556 |
South Asian | 0.000393 | 0.000392 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an essential role for cellular polarization, directed cell migration and modulating cell-cell contact. {ECO:0000250}.;
- Pathway
- Primary Focal Segmental Glomerulosclerosis FSGS;mechanism of gene regulation by peroxisome proliferators via ppara
(Consensus)
Recessive Scores
- pRec
- 0.171
Intolerance Scores
- loftool
- 0.712
- rvis_EVS
- -0.39
- rvis_percentile_EVS
- 27.06
Haploinsufficiency Scores
- pHI
- 0.436
- hipred
- Y
- hipred_score
- 0.593
- ghis
- 0.507
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.652
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Fat1
- Phenotype
- immune system phenotype; renal/urinary system phenotype; skeleton phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- fat1a
- Affected structure
- pronephros
- Phenotype tag
- abnormal
- Phenotype quality
- cystic
Gene ontology
- Biological process
- epithelial cell morphogenesis;actin filament organization;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;establishment or maintenance of cell polarity;cell-cell signaling;anatomical structure morphogenesis;cell migration;establishment or maintenance of epithelial cell apical/basal polarity;camera-type eye morphogenesis;cell-cell adhesion
- Cellular component
- nucleus;plasma membrane;integral component of plasma membrane;cell-cell junction;focal adhesion;apical plasma membrane;lamellipodium;filopodium;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- calcium ion binding;protein binding